{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:02:50Z","timestamp":1784073770194,"version":"3.55.0"},"reference-count":55,"publisher":"Baishideng Publishing Group Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4254\/wjh.v8.i9.452","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T02:59:25Z","timestamp":1458788365000},"page":"452","source":"Crossref","is-referenced-by-count":11,"title":["Comprehensive review of telbivudine in pregnant women with chronic hepatitis B"],"prefix":"10.4254","volume":"8","author":[{"given":"Teerha","family":"Piratvisuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo Rong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Trylesinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.06.008"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(05)00384-7"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01933.x"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197504102921503"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-1850.","DOI":"10.1016\/0016-5085(87)90614-7"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02096.x"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.4.599"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.30"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12060"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00080-7"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1993.02160360058019"},{"key":"ref12","unstructured":"Farmer K, Gunn T, Woodfield DG. A combination of hepatitis B vaccine and immunoglobulin does not protect all infants born to hepatitis B e antigen positive mothers. N Z Med J 1987;100:412-414."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e45951"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.01.101"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, Maley MW, Ayres A, Locarnini SA, Levy MT. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009;190:489-492.","DOI":"10.5694\/j.1326-5377.2009.tb02524.x"},{"key":"ref17","unstructured":"Pan CQ, Duan ZP, Dai E, Zhang S, Han GR, Wang Y, Zhang H, Zou H, Zhu BS, Zhao WJ. Tenofovir disoproxil fumarate (TDF) reduces perinatal transmission of hepatitis B virus in highly viremic mothers: a multi-center, prospective, randomized and controlled study. Hepatology 2015;62:316A."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.026"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12025"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066422"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12525"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.09.002"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9365-4"},{"key":"ref24","unstructured":"Antiretroviral Pregnancy Registry Interim Report 2015; Available from: http:\/\/www.apregistry.com\/forms\/interim_report.pdf<\/ext-link>."},{"key":"ref25","unstructured":"Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data. EMEA\/CHMP\/313666\/2005. [Accessed 2013 Sept 16] Available from: http:\/\/www.ema.europa.eu\/docs\/en...guideline\/...\/WC500011303.pdf\u200e<\/ext-link>."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27034"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.08.043"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12066"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001635"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-011-0328-y"},{"key":"ref31","unstructured":"Shih IH, Lin JY, Chen CH, Hong HS. A birthmark survey in 500 newborns: clinical observation in two northern Taiwan medical center nurseries. Chang Gung Med J 2007;30:220-225."},{"key":"ref32","unstructured":"Altunta\u015f EE, Nur N, Cerrah YS, Müderris S. A study of the prevalence of developmental anomalies of the external ear among preschool children in Sivas, Turkey. Turk J Pediatr 2011;53:528-531."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5876(01)00639-5"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-011-0326-0"},{"key":"ref35","unstructured":"US National Birth Defects Prevention Network. [Accessed 2013 Sept 17]. Available from: http:\/\/www.nbdpn.org\/<\/ext-link>."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-185"},{"key":"ref37","unstructured":"Xu HX, Wang LJ, Yu YX, Wu YP, Xu YF, Liu XX, Chen Y. [Efficacy and safety of telbivudine treatment to block mother-to-child transmission of hepatitis B virus: a meta-analysis]. Zhonghua Gan Zang Bing Za Zhi 2012;20:755-760."},{"key":"ref38","unstructured":"Liu M, Li L, Wang L, Cai H. Preliminary observation on efficacy and safety of telbivudine for preventing mother-to-infant HBV vertical transmission in five HBV-infected pregnant women. Adverse Drug React 2008;10:19-21."},{"key":"ref39","unstructured":"Peng B, Zhao Y, Yang X. Evaluation of the efficacy and safety of telbivudine in preventing mother-to-infant HBV transmission. Zhongguo Yaolixue Tongbao 2012;47:855-857."},{"key":"ref40","unstructured":"Zeng Y, Zhang S, Lou G. Clinical study on preventing baby infections in uterine from hepatitis B virus with telbivudine. Zhongguo Linchuang Yaolixue Zazhi 2010;15:443-445."},{"key":"ref41","unstructured":"Zhang LJ, Wang L. [Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi 2009;17:561-563."},{"key":"ref42","unstructured":"Zhang Y, Hu Y. Efficacy and safety of telbivudine in blocking mother to child transmission of hepatitis B. Adverse Drug React 2010;12:157-159."},{"key":"ref43","unstructured":"Zhou YJ, Zheng JL, Pan HJ, Jiang S. [Efficacy and safety of telbivudine in pregnant chronic hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi 2011;19:861-862."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.06.005"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2014.08.004"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2015.01.004"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12379"},{"key":"ref48","unstructured":"European Surveillance of Congenital Anomalies. [Accessed 2013 Sept 17]. Available from: http:\/\/www.eurocat-network.eu\/\u200e<\/ext-link>."},{"key":"ref49","unstructured":"Metropolitan Atlanta Congenital Defects Program. [Accessed 2013 Sept 18]. Available from: http:\/\/www.cdc.gov\/ncbddd\/birthdefects\/macdp.html<\/ext-link>."},{"key":"ref50","unstructured":"Christianson A, Howson C, Modell B. Global report on birth defects. The hidden toll of dying and disabled children. March of Dimes New York: March of Dimes Birth Defects Foundation White Plains; 2006;."},{"key":"ref51","unstructured":"Center for Disease Control in US. [Accessed 2013 Sept 18]. Available from: http:\/\/www.cdc.gov\/<\/ext-link>."},{"key":"ref52","unstructured":"Abortion in Europe. Entre Nous 59 2005; Available from: http:\/\/www.euro.who.int\/en\/what-we-do\/health-topics\/Life-stages\/sexual-and-reproductive-health\/publications\/entre-nous\/entre-nous\/abortion-in-europe.-entre-nous-59<\/ext-link>."},{"key":"ref53","unstructured":"Jiang Q, Liang W, Zhang S. New research for efficacy of telbivudine blocking HBV transmission from mother to child. Zhonghua Shiyan He Linchang Bingduxue Zazhi 2010;24:286-288."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4103\/0972-9747.76912"},{"key":"ref55","unstructured":"Zhao D, Liao X, Peng G. Efficacy of telbivudine combined with hepatitis B vaccine and hepatitis B immune globulin for preventing mother-to-infant transmission in sixty HBV-infected pregnant women. Zhongguo Xiandai Yaowu Yingyong 2010;4:37-38."}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v8\/i9\/452.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T18:26:37Z","timestamp":1600367197000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v8\/i9\/452.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v8.i9.452","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}